Betsy Smith

发表

Clinical Response and Tolerability to and Safety of Saquinavir with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Mothers and Their Infants

M. Hughes, L. Mofenson, E. Acosta, 2007, Antimicrobial Agents and Chemotherapy.

Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children

A. Diacon, L. Wiesner, S. Nachman, 2018, British journal of clinical pharmacology.

Feasibility of Identifying Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.

M. Hughes, S. Swindells, U. Lalloo, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.

J. Mascola, G. Theron, B. Graham, 2021, The Journal of infectious diseases.

Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants.

J. Mascola, J. Safrit, L. Mofenson, 2020, The Journal of infectious diseases.

Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV‐infected children 4 weeks to 18 years of age

H. Teppler, E. Acosta, M. Rizk, 2015, Journal of clinical pharmacology.

Pharmacokinetics and tolerance of zidovudine in preterm infants.

L. Mofenson, J. Connor, S. Blanchard, 2003, The Journal of pediatrics.

Dynamics of Human Immunodeficiency Virus Type 1 Replication in Vertically Infected Infants

W. Borkowsky, L. Mofenson, Hulin Wu, 1999, Journal of Virology.

Raltegravir (RAL) in neonates: Dosing, pharmacokinetics (PK), and safety in HIV-1 exposed neonates at risk of infection (IMPAACT P1110).

S. Spector, H. Teppler, E. Acosta, 2020, Journal of acquired immune deficiency syndromes.

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110.

H. Teppler, E. Acosta, E. Capparelli, 2019, Journal of acquired immune deficiency syndromes.

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines

S. Spector, G. Siberry, E. Capparelli, 2018, The Pediatric infectious disease journal.

Willingness to Take Multidrug-Resistant Tuberculosis (MDR-TB) Preventive Therapy among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multi-Site Cross-Sectional Study.

M. Hughes, S. Swindells, U. Lalloo, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.

D. Nalin, S. Chandwani, J. Moye, 2011, The Journal of infectious diseases.

Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel.

S. Hernández-Díaz, K. Dooley, J. Albano, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel.

S. Kabra, L. Dodd, S. Swaminathan, 2012, The Journal of infectious diseases.

Dynamics of Human Immunodeficiency Virus Type 1 Replication in Vertically Infected Infants

W. Borkowsky, L. Mofenson, Hulin Wu, 1999, Journal of Virology.